Measuring the Impact of the COVID-19 Pandemic on Diagnostic Delay in Rare Disease

Rare diseases are individually rare but collectively common, with a combined prevalence of 3.5–5.9%. A common feature of many diseases is a substantial delay in patients receiving a correct diagnosis; this protracted path to diagnosis is termed ‘the diagnostic odyssey’. During the COVID-19 pandemic...

Full description

Saved in:
Bibliographic Details
Main Authors: Caitlin Hampson, William Evans, Lucy McKay, Lara Menzies
Format: Article
Language:English
Published: European Medical Journal 2022-07-01
Series:European Medical Journal
Online Access:https://www.emjreviews.com/innovations/article/measuring-the-impact-of-the-covid-19-pandemic-on-diagnostic-delay-in-rare-disease/
Tags: Add Tag
No Tags, Be the first to tag this record!